SCHEMBL24442343

SCHEMBL24442343

NC(=O)c1c(N)n[nH]c1-c1ccc(Oc2ccccc2)cc1

nearest known ligand 0.53

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ PIK3CD O00329 1/20 0.52
▸ NUDT14 O95848 1/20 0.52
▸ PIK3CA P42336 1/20 0.52
▸ PIK3CB P42338 1/20 0.52
▸ PIK3CG P48736 1/20 0.52
▸ PRKDC P78527 1/20 0.52
▸ NUDT5 Q9UKK9 1/20 0.52
▸ LCK P06239 1/20 0.52
▸ SRC P12931 1/20 0.52
▸ CSK P41240 1/20 0.52
▸ BTK Q06187 12/20 0.50
▸ HTT P42858 1/20 0.50
▸ MAPK10 P53779 1/20 0.50
▸ SMN1; SMN2 Q16637 1/20 0.50
▸ EGFR P00533 1/20 0.49
▸ PARP10 Q53GL7 1/20 0.47
▸ SCN9A Q15858 1/20 0.44
▸ RPS6KA3 P51812 1/20 0.43
▸ CHEK2 O96017 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16197120 0.78 SCN9A (0.50) LCKSRCCSKBTKPARP10
SCHEMBL15756520 0.75 CHEK1 (0.46) BTK
SCHEMBL202119 0.73 PIK3CD (0.53) PIK3CDNUDT14PIK3CAPIK3CBPIK3CG
SCHEMBL15074564 0.73 MAPK1 (0.44) PIK3CDPIK3CAPIK3CBPIK3CGPRKDC
SCHEMBL29709430 0.72 LCK (0.45) LCKBTKSCN9A
SCHEMBL28849703 0.70 KMT2A (0.46) SMN1; SMN2RPS6KA3
SCHEMBL28034854 0.69 SCN9A (0.52) BTKEGFRPARP10SCN9ACHEK2
SCHEMBL25649413 0.69 BTK (0.49) BTKPARP10SCN9A
SCHEMBL3135351 0.68 PLAU (0.55) BTKPARP10SCN9ACHEK2
SCHEMBL23239650 0.68 BTK (0.60) NUDT14NUDT5SRCBTKEGFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240018152-A1 NOVEL PROCESS FOR THE PREPARATION OF (S)-7-(1-ACRYLOYLPIPERIDIN-4-YL)-2-(4-PHENOXYPHENYL)-4,5,6,7-TETRAHYDROPYRAZOLO[1,5-A]PYRIMIDINE-3-CARBOXAMIDE OR ITS SALTS THEREOF MSN LABORATORIES PRIVATE LIMITED, R&D CENTER (IN) 2024-01-18 — — US disclosed
US-20240018152-A1 NOVEL PROCESS FOR THE PREPARATION OF (S)-7-(1-ACRYLOYLPIPERIDIN-4-YL)-2-(4-PHENOXYPHENYL)-4,5,6,7-TETRAHYDROPYRAZOLO[1,5-A]PYRIMIDINE-3-CARBOXAMIDE OR ITS SALTS THEREOF MSN LABORATORIES PRIVATE LIMITED, R&D CENTER (IN) 2024-01-18 — — US disclosed
US-20240018152-A1 NOVEL PROCESS FOR THE PREPARATION OF (S)-7-(1-ACRYLOYLPIPERIDIN-4-YL)-2-(4-PHENOXYPHENYL)-4,5,6,7-TETRAHYDROPYRAZOLO[1,5-A]PYRIMIDINE-3-CARBOXAMIDE OR ITS SALTS THEREOF MSN LABORATORIES PRIVATE LIMITED, R&D CENTER (IN) 2024-01-18 — — US disclosed
WO-2022101939-A1 NOVEL PROCESS FOR THE PREPARATION OF (S)-7-(1-ACRYLOYLPIPERIDIN-4-YL)-2-(4-PHENOXYPHENYL)-4,5,6,7-TETRAHYDROPYRAZOLO[1,5-A]PYRIMIDINE-3-CARBOXAMIDE OR ITS SALTS THEREOF MSN LABORATORIES PRIVATE LIMITED, R&D CENTER (IN) 2022-05-19 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240018152-A1 NOVEL PROCESS FOR THE PREPARATION OF (S)-7-(1-ACRYLOYLPIPERIDIN-4-YL)-2-(4-PHENOXYPHENYL)-4,5,6,7-TETRAHYDROPYRAZOLO[1,5-A]PYRIMIDINE-3-CARBOXAMIDE OR ITS SALTS THEREOF CYP3A7, UGT1A7, UGT2B7 PIK3CD 1582/4885NUDT14 775/4885PIK3CA 921/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback